Merck & Co. got a lukewarm “neutral” rating from Citigroup, along with a price target drop from $115 to $84. Other analysts ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Merck is facing an awkward encore as one of the worst-performing blue chip stocks in 2025, sliding 23.3% year-to-date.

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at ...

C4 Therapeutics, Inc.’s CCCC share price has surged by 12.77%, which has investors questioning if this is right time to sell.

Major U.S. equities indexes were mostly lower at midday amid concerns about tariffs and anticipation of this week's Fed ...

and Merck Sharp & Dohme, LLC, as well as Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts. Want to learn more about C4 Therapeutics, Inc.

Merck’s stock was gaining after the drugmaker beat quarterly earnings expectations again and maintained its full-year outlook despite additional costs related to tariffs. Photo: Getty Images ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Since early April, the market has recovered significantly, and she attributed the rally to better-than-expected profit margins and steady corporate performance ... stock that is more promising ...